Literature DB >> 7860398

Repopulation kinetics during fractionated irradiation and the relationship to the potential doubling time, Tpot.

A K Speke1, R P Hill.   

Abstract

PURPOSE: Therapeutic outcome may be adversely affected by repopulation in solid tumors during fractionated irradiation. It has been proposed that the repopulation rate of the surviving cells may be reflected by the pretreatment potential doubling time (Tpot). This concept has been examined by comparing pretreatment Tpot measurements to repopulation monitored in five transplantable murine tumors during fractionated radiation treatment. METHODS AND MATERIALS: Up to nine fractions of 2 Gy were given to clamped tumors on a 6 h schedule, which allowed adequate time for repair, or on a 24 h schedule, which incorporated more time for repopulation. Tumors were removed from treatment at various times and tumor cell survival was analyzed using an excision assay. The ratio of the cell survival in tumors treated with the same total dose on the two different fractionation schedules (24 h/6 h) was used to calculate an effective doubling time for repopulation during the treatment (Teff). Potential doubling time was assessed in untreated tumors by giving the tumor-bearing animals 5-bromodeoxyuridine (BrdUrd) and, at various times later, removing the tumors for flow cytometric analysis. Tpot values were calculated by two different widely used methods.
RESULTS: For four tumors (RIF-1, KHT-C, KHT-LP1, and B16-F1), the Teff was greater than Tpot indicating that repopulation was not as rapid as suggested by Tpot. For SCC-VII, the only carcinoma tested, Teff was smaller than Tpot indicating that repopulation was more rapid than predicted by Tpot. Individual estimates of Tpot made from single tumor samples taken at different times after BrdUrd administration varied by factors of 2 to 7 for the different tumors.
CONCLUSION: These findings indicate a need for caution in applying measurements of Tpot for prediction of regrowth rates in individual patients' tumors.

Entities:  

Mesh:

Year:  1995        PMID: 7860398     DOI: 10.1016/0360-3016(94)00496-X

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  3 in total

Review 1.  Can drugs enhance hypofractionated radiotherapy? A novel method of modeling radiosensitization using in vitro data.

Authors:  Nitin Ohri; Adam P Dicker; Yaacov Richard Lawrence
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-01-19       Impact factor: 7.038

2.  Low dose angiostatic treatment counteracts radiotherapy-induced tumor perfusion and enhances the anti-tumor effect.

Authors:  Esther A Kleibeuker; Emmanouil Fokas; Philip D Allen; Veerle Kersemans; Arjan W Griffioen; John Beech; Jaehong H Im; Sean C Smart; Kitty C Castricum; Jaap van den Berg; Iris A Schulkens; Sally A Hill; Adrian L Harris; Ben J Slotman; Henk M Verheul; Ruth J Muschel; Victor L Thijssen
Journal:  Oncotarget       Date:  2016-11-22

3.  Changes in cell proliferative parameters of SCCVII and EMT6 murine tumors after single-dose irradiation.

Authors:  R Murata; Y Nishimura; Y Shibamoto; M Hiraoka; M Abe
Journal:  Jpn J Cancer Res       Date:  1996-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.